Filed: 11/13/2023ACC: 0001420506-23-001985
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 80 equity positions with a total reported market value of $329.82M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
80
Positions
$329.82M
Total AUM (reported)
45.54M
Total Shares
Allocation by class
EQUITIES$268.41M81.4%
LONG OPTION CALLS$52.99M16.1%
LONG OPTION PUTS$8.39M2.5%
WARRANTS$17.8K0.0%
Portfolio Concentration
Top 3$56.19M17.0%
4–10$69.70M21.1%
11–25$97.67M29.6%
Rest$106.26M32.2%
Top 3 weight
17.0%
Top 10 weight
38.2%
Voting Authority Distribution
Total shares with voting rights: 45.54M
Sole
Full voting authority
45.54M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole80
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings80
Rows:
SPRD S&P Biotech ETF
SOLEShares300K
TypeSH
Market value$21.91M
6.64%
Sole
300K
Shared
0.00
None
0.00
ImmunoGen Inc
SOLEShares1.31M
TypeSH
Market value$20.75M
6.29%
Sole
1.31M
Shared
0.00
None
0.00
Morphic Holding Inc
SOLEShares590.83K
TypeSH
Market value$13.54M
4.10%
Sole
590.83K
Shared
0.00
None
0.00
Merus NV
SOLEShares500K
TypeSH
Market value$11.79M
3.57%
Sole
500K
Shared
0.00
None
0.00
Soleno Therapeutics Inc
SOLEShares370K
TypeSH
Market value$10.92M
3.31%
Sole
370K
Shared
0.00
None
0.00
Intra-Cellular Therapies Inc
SOLEShares208.73K
TypeSH
Market value$10.87M
3.30%
Sole
208.73K
Shared
0.00
None
0.00
Akero Therapeutics Inc
SOLEShares200K
TypeSH
Market value$10.12M
3.07%
Sole
200K
Shared
0.00
None
0.00
CymaBay Therapeutics Inc
SOLEShares590K
TypeSH
Market value$8.80M
2.67%
Sole
590K
Shared
0.00
None
0.00
Mirati Therapeutics Inc
SOLEShares200K
TypeSH
Market value$8.71M
2.64%
Sole
200K
Shared
0.00
None
0.00
Poseida Therapeutics Inc
SOLEShares3.57M
TypeSH
Market value$8.49M
2.57%
Sole
3.57M
Shared
0.00
None
0.00
Krystal Biotech Inc
SOLEShares71.53K
TypeSH
Market value$8.30M
2.52%
Sole
71.53K
Shared
0.00
None
0.00
Biogen Idec Inc
SOLEShares28.07K
TypeSH
Market value$7.21M
2.19%
Sole
28.07K
Shared
0.00
None
0.00
Urogen Pharma Ltd
SOLEShares508.88K
TypeSH
Market value$7.13M
2.16%
Sole
508.88K
Shared
0.00
None
0.00
United Therapeutics Corp
SOLEShares31.42K
TypeSH
Market value$7.10M
2.15%
Sole
31.42K
Shared
0.00
None
0.00
Praxis Precision Medicines Inc
SOLEShares4.12M
TypeSH
Market value$7.04M
2.14%
Sole
4.12M
Shared
0.00
None
0.00
Oric Pharmaceuticals Inc
SOLEShares1.12M
TypeSH
Market value$6.80M
2.06%
Sole
1.12M
Shared
0.00
None
0.00
Crinetics Pharmaceuticals Inc
SOLEShares220K
TypeSH
Market value$6.54M
1.98%
Sole
220K
Shared
0.00
None
0.00
Mirati Therapeutics Inc
SOLEShares150K
TypeSH
Market value$6.53M
1.98%
Sole
150K
Shared
0.00
None
0.00
Cogent Biosciences Inc
SOLEShares651.37K
TypeSH
Market value$6.35M
1.93%
Sole
651.37K
Shared
0.00
None
0.00
Mersana Therapeutics Inc
SOLEShares5M
TypeSH
Market value$6.35M
1.93%
Sole
5M
Shared
0.00
None
0.00
Rhythm Pharmaceuticals Inc
SOLEShares260.54K
TypeSH
Market value$5.97M
1.81%
Sole
260.54K
Shared
0.00
None
0.00
MacroGenics Inc
SOLEShares1.26M
TypeSH
Market value$5.89M
1.79%
Sole
1.26M
Shared
0.00
None
0.00
BioCryst Pharmaceuticals Inc
SOLEShares791.67K
TypeSH
Market value$5.61M
1.70%
Sole
791.67K
Shared
0.00
None
0.00
Novo Nordisk A/S
SOLEShares60K
TypeSH
Market value$5.46M
1.65%
Sole
60K
Shared
0.00
None
0.00
Akero Therapeutics Inc
SOLEShares106.60K
TypeSH
Market value$5.39M
1.63%
Sole
106.60K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPRD S&P Biotech ETFSOLE | LONG OPTION CALLS | 300K | SH | $21.91M 6.64% | 300K | 0.00 | 0.00 |
ImmunoGen IncSOLE | EQUITIES | 1.31M | SH | $20.75M 6.29% | 1.31M | 0.00 | 0.00 |
Morphic Holding IncSOLE | EQUITIES | 590.83K | SH | $13.54M 4.10% | 590.83K | 0.00 | 0.00 |
Merus NVSOLE | EQUITIES | 500K | SH | $11.79M 3.57% | 500K | 0.00 | 0.00 |
Soleno Therapeutics IncSOLE | EQUITIES | 370K | SH | $10.92M 3.31% | 370K | 0.00 | 0.00 |
Intra-Cellular Therapies IncSOLE | EQUITIES | 208.73K | SH | $10.87M 3.30% | 208.73K | 0.00 | 0.00 |
Akero Therapeutics IncSOLE | LONG OPTION CALLS | 200K | SH | $10.12M 3.07% | 200K | 0.00 | 0.00 |
CymaBay Therapeutics IncSOLE | EQUITIES | 590K | SH | $8.80M 2.67% | 590K | 0.00 | 0.00 |
Mirati Therapeutics IncSOLE | EQUITIES | 200K | SH | $8.71M 2.64% | 200K | 0.00 | 0.00 |
Poseida Therapeutics IncSOLE | EQUITIES | 3.57M | SH | $8.49M 2.57% | 3.57M | 0.00 | 0.00 |
Krystal Biotech IncSOLE | EQUITIES | 71.53K | SH | $8.30M 2.52% | 71.53K | 0.00 | 0.00 |
Biogen Idec IncSOLE | EQUITIES | 28.07K | SH | $7.21M 2.19% | 28.07K | 0.00 | 0.00 |
Urogen Pharma LtdSOLE | EQUITIES | 508.88K | SH | $7.13M 2.16% | 508.88K | 0.00 | 0.00 |
United Therapeutics CorpSOLE | EQUITIES | 31.42K | SH | $7.10M 2.15% | 31.42K | 0.00 | 0.00 |
Praxis Precision Medicines IncSOLE | EQUITIES | 4.12M | SH | $7.04M 2.14% | 4.12M | 0.00 | 0.00 |
Oric Pharmaceuticals IncSOLE | EQUITIES | 1.12M | SH | $6.80M 2.06% | 1.12M | 0.00 | 0.00 |
Crinetics Pharmaceuticals IncSOLE | EQUITIES | 220K | SH | $6.54M 1.98% | 220K | 0.00 | 0.00 |
Mirati Therapeutics IncSOLE | LONG OPTION CALLS | 150K | SH | $6.53M 1.98% | 150K | 0.00 | 0.00 |
Cogent Biosciences IncSOLE | EQUITIES | 651.37K | SH | $6.35M 1.93% | 651.37K | 0.00 | 0.00 |
Mersana Therapeutics IncSOLE | EQUITIES | 5M | SH | $6.35M 1.93% | 5M | 0.00 | 0.00 |
Rhythm Pharmaceuticals IncSOLE | EQUITIES | 260.54K | SH | $5.97M 1.81% | 260.54K | 0.00 | 0.00 |
MacroGenics IncSOLE | EQUITIES | 1.26M | SH | $5.89M 1.79% | 1.26M | 0.00 | 0.00 |
BioCryst Pharmaceuticals IncSOLE | EQUITIES | 791.67K | SH | $5.61M 1.70% | 791.67K | 0.00 | 0.00 |
Novo Nordisk A/SSOLE | EQUITIES | 60K | SH | $5.46M 1.65% | 60K | 0.00 | 0.00 |
Akero Therapeutics IncSOLE | LONG OPTION PUTS | 106.60K | SH | $5.39M 1.63% | 106.60K | 0.00 | 0.00 |
Page 1 of 4